US Q3 2026 Earnings: Tenable, Biogen, and Regional Banks Deliver Broad Beats
Tenable Holdings beat Q3 guidance with $276.4M revenue and 59% record Tenable One new business adoption
Key points
- Tenable beats Q3 guidance with $276.4M revenue and record 59% Tenable One adoption
- Biogen raises 2026 EPS guidance to $12.20-$13.00 on LEQEMBI and SPINRAZA growth
- Regional banks NBT and Northwest post record net interest income in rate-supportive environment
Does this change your view on the stock? Share your take below.
Read the full analysis on market.news
🇺🇸 United States Stocks Earnings earnings-beat tech pharma banking financials